Solazyme and Unilever Partner to Bring Algal Renewable Oil to Personal Care Products

March 9, 2010

For Immediate Release

Research and development agreement to develop renewable, natural and sustainable oils from algae for use in soaps and other personal care products

SOUTH SAN FRANSISCO, California (March 9, 2010) —Solazyme, Inc., a renewable oil and bioproducts company, has signed a research and development agreement with Unilever to develop oil derived from algae for use in soaps and other personal care products. The agreement follows the culmination of a yearlong collaboration between Solazyme and Unilever, in which Solazyme's renewable algal oils were tested successfully in Unilever product formulations.

"Algal oil provides important benefits in personal care applications," explained Jonathan Wolfson, CEO of Solazyme. "Solazyme's algal oils can help meet the growing demand for completely renewable, natural and sustainable personal care products. Unilever is an acknowledged world leader in sustainability and we are honored to be working with them to develop this new renewable source of natural oils for their world class consumer products."

Solazyme and Unilever are working to demonstrate a process to incorporate targeted algal oils into personal care products at a commercially relevant scale. The work will further develop Solazyme's technology platform, which allows algae to produce oil and biomaterials in standard fermentation facilities quickly, efficiently and at large scale.

Among other sustainability initiatives, Unilever is vigorously exploring various next-generation sources of renewable oil for use in its products. Unilever's collaboration with Solazyme represents a substantial step in the company's exploration of algae as a source of renewable oil.

"Unilever is committed to the highest sustainability and environmental practices and is working to drive industry change and set new standards," said Peter Gallagher, VP of Global Skin R&D, of Unilever. "Exploring sources of alternative natural oils, is one of the most important aspects of our greater sustainable sourcing strategy and working with Solazyme's algal oils is an excellent fit."

For more information, please visit www.solazyme.com.

About Solazyme

Solazyme, Inc. is a renewable oil company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s proprietary technology transforms a range of low-cost plant-based sugars into high-value oils. Our renewable products can replace or enhance oils derived from the world’s three existing sources—petroleum, plant and animal fats. We tailor the composition of our oils to address specific customer requirements, offering superior performance characteristics at a competitive cost to conventional oils. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme's investors, among others, include Braemar Energy Ventures, Harris & Harris Group, Lightspeed Venture Partners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures. For more information, please visit www.solazyme.com.

For more information

Genet Garamendi
VP, Corporate Communications
(650) 963-5228
press@solazyme.com

About Braemar Energy Ventures

Braemar Energy Ventures is a venture capital fund making early- to mid-stage investments in the energy technology sector. The firm's principals have invested in more than 60 companies in the sector and have more than 100 years of combined technical, operational and financial experience in energy and energy-related industries. Braemar partners with exceptional companies and management teams, in both alternative and traditional energy markets, that can contribute to a more profitable and efficient energy landscape through innovation and marketplace expertise. Additional information is available at BraemarEnergy.com or on Twitter at twitter.com/braemarenergy or @BraemarEnergy.

For more information

Alison McIntyre
Prosek Partners
(212) 279-3115 x269
amcintyre@prosek.com